Total Payments
$6,379
2024 Payments
$50.37
Companies
38
Transactions
472
Medicare Patients
778
Medicare Billing
$55,263
Payment Breakdown by Category
Food & Beverage$6,282 (98.5%)
Education$97.10 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,282 | 466 | 98.5% |
| Education | $97.10 | 6 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,197 | 119 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $692.00 | 43 | $0 (2021) |
| GlaxoSmithKline, LLC. | $594.16 | 49 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $570.68 | 32 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $524.73 | 32 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $412.02 | 37 | $0 (2020) |
| Allergan Inc. | $399.83 | 37 | $0 (2018) |
| Amgen Inc. | $251.33 | 14 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $214.05 | 9 | $0 (2020) |
| Lilly USA, LLC | $199.03 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.37 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($25.80) |
| 2023 | $24.67 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($24.67) |
| 2022 | $19.50 | 1 | Amgen Inc. ($19.50) |
| 2021 | $169.24 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($68.66) |
| 2020 | $487.90 | 32 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($59.08) |
| 2019 | $2,016 | 129 | Novo Nordisk Inc ($473.71) |
| 2018 | $1,654 | 125 | Novo Nordisk Inc ($389.93) |
| 2017 | $1,957 | 171 | Novo Nordisk Inc ($289.70) |
All Payment Transactions
472 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Gastroenterology | ||||||
| 08/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/13/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Inflammation | ||||||
| 09/16/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/14/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Respiratory | ||||||
| 05/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Gastroenterology | ||||||
| 03/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Gastroenterology | ||||||
| 03/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Gastroenterology | ||||||
| 03/11/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/01/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Cardiovascular | ||||||
| 02/25/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.79 | General |
| 02/02/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Gastroenterology | ||||||
| 01/21/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/12/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $16.00 | General |
| Category: Cardiovascular | ||||||
| 12/21/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Diabetes | ||||||
| 12/17/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Endocrinology | ||||||
| 11/16/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Endocrinology | ||||||
| 10/19/2020 | E.R. Squibb & Sons, L.L.C. | ABILIFY (Drug) | Education | Cash or cash equivalent | $14.04 | General |
| Category: Neuroscience | ||||||
| 10/07/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/05/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Endocrinology | ||||||
| 05/28/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Endocrinology | ||||||
| 04/08/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Neuroscience | ||||||
| 03/26/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 321 | 408 | $39,286 | $25,479 |
| 2020 | 10 | 457 | 562 | $48,389 | $29,784 |
Total Patients
778
Total Services
970
Medicare Billing
$55,263
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 177 | $18,805 | $11,183 | 59.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 88 | 88 | $14,080 | $10,975 | 78.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 19 | $2,710 | $1,623 | 59.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 33 | $2,490 | $1,327 | 53.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 78 | 79 | $553.00 | $271.44 | 49.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $648.00 | $99.27 | 15.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 112 | 196 | $20,355 | $11,791 | 57.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 87 | 87 | $13,990 | $9,478 | 67.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 17 | 17 | $3,060 | $2,704 | 88.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 54 | $3,985 | $2,375 | 59.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 18 | $2,580 | $1,448 | 56.1% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 15 | 16 | $1,200 | $600.10 | 50.0% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 19 | 19 | $570.00 | $521.59 | 91.5% |
| 81002 | Urinalysis, manual test | Office | 2020 | 101 | 110 | $770.00 | $381.19 | 49.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 19 | $475.00 | $295.85 | 62.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 26 | 26 | $1,404 | $188.93 | 13.5% |
About Dr. Ann Pollock, MD
Dr. Ann Pollock, MD is a Internal Medicine healthcare provider based in Frankfort, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518966209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Pollock, MD has received a total of $6,379 in payments from pharmaceutical and medical device companies, with $50.37 received in 2024. These payments were reported across 472 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,282).
As a Medicare-enrolled provider, Pollock has provided services to 778 Medicare beneficiaries, totaling 970 services with total Medicare billing of $55,263. Data is available for 2 years (2020–2021), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Frankfort, KY
- Active Since 07/15/2005
- Last Updated 01/20/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518966209
Products in Payments
- FARXIGA (Drug) $316.38
- JANUVIA (Drug) $309.53
- Tresiba (Drug) $295.11
- Victoza (Drug) $267.91
- Ozempic (Drug) $266.72
- Saxenda (Drug) $247.18
- SOLIQUA (Drug) $234.33
- XIFAXAN (Drug) $226.67
- JARDIANCE (Drug) $214.82
- ANORO (Drug) $199.51
- TRELEGY ELLIPTA (Drug) $194.40
- ENTRESTO (Drug) $188.75
- LINZESS (Drug) $158.09
- SYMBICORT (Drug) $144.75
- Aimovig (Biological) $143.66
- BREO (Drug) $136.50
- SOLIQUA 100/33 (Drug) $130.26
- TOUJEO (Drug) $124.68
- INTRAROSA (Drug) $115.96
- MOVANTIK (Drug) $105.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Frankfort
Saurabh Parasramka, Md, MD
Internal Medicine — Payments: $5,140
Internal Medicine $5,140
Dr. Evan Dicken, M.d, M.D
Internal Medicine — Payments: $3,579
Internal Medicine $3,579
Rachna Garg, M.d, M.D
Internal Medicine — Payments: $3,302
Internal Medicine $3,302
Neeraj Mahboob, Md, MD
Internal Medicine — Payments: $1,563
Internal Medicine $1,563
Dr. Roger Strunk, Md, MD
Internal Medicine — Payments: $1,229
Internal Medicine $1,229
Dr. Bushra Alam, Do, DO
Internal Medicine — Payments: $1,190
Internal Medicine $1,190